BSIC | Bocconi Students Investment Club
  • Articles
    • Markets
    • Corporate Finance
  • The Team
    • Members
    • Alumni
  • About Us
  • Gallery
  • Join Us
  • Contacts
  • Subscribe
  • Collaborations

Gene therapy

Corporate Finance Old Articles

Novartis-AveXis: an $8.7bn gene repair

Novartis AG (SIX: NOVN) – market cap as of 20/04/2018: CHF204.12bn AveXis Inc (NASDAQ: AVXS) – market cap as of 20/04/2018: $7.62bn Introduction On April 9, Novartis submitted an offer to acquire all the shares of the American gene therapy group AveXis. The Swiss drugmaker offered an 88% premium adding Read more…

By BSIC, 7 years22 April 2018 ago

[instagram-feed]

Follow Us

  • Disclaimer
  • About Us
  • Join Us
  • Contacts
  • Subscribe
  • Privacy Policy
  • Cookie Policy
Hestia | Developed by ThemeIsle